SCHEMBL10744532

SCHEMBL10744532

S=c1c2ccccc2[se]n1-c1nccc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 1/20 0.44
▸ HTR2C P28335 1/20 0.44
▸ COMT P21964 1/20 0.40
▸ PLAU P00749 2/20 0.40
▸ NCF1 P14598 2/20 0.40
▸ CYP2A6 P11509 1/20 0.40
▸ F12 P00748 1/20 0.40
▸ NOS3 P29474 1/20 0.40
▸ NOS1 P29475 1/20 0.40
▸ NOS2 P35228 1/20 0.40
▸ BACE1 P56817 1/20 0.40
▸ SORD Q00796 2/20 0.39
▸ PLG P00747 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ QSOX1 O00391 1/20 0.36
▸ RGS12 O14924 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5916583 0.81 METAP2 (0.54) COMTNCF1ALDH1A1LMNAMAPT
SCHEMBL11022181 0.81 METAP2 (0.36) HRH4NCF1CYP2A6NOS3NOS2
SCHEMBL10502118 0.79 NPSR1 (0.44) NCF1ALDH1A1LMNAMAPTKDM4E
SCHEMBL10747582 0.77 METAP2 (0.40) NCF1ALDH1A1LMNAMAPTKDM4E
SCHEMBL10502474 0.74 ALDH1A1 (0.38) NCF1ALDH1A1LMNAMAPTKDM4E
SCHEMBL10502218 0.74 CYP1A2 (0.47) HTR2CALDH1A1LMNAMAPTKDM4E
SCHEMBL10744770 0.73 KDM4E (0.44) NCF1CYP2A6SORDALDH1A1LMNA
SCHEMBL10502470 0.72 METAP2 (0.46) NCF1ALDH1A1LMNAMAPTKDM4E
SCHEMBL10501684 0.72 SMN1; SMN2 (0.45) ALDH1A1LMNAMAPTKDM4EGLA
SCHEMBL10501411 0.72 METAP2 (0.38) NCF1ALDH1A1LMNAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback